Zhenghai Biologics: Currently conducting relevant planning work for product internationalization.

Sinobioway Biomedicine stated during an institutional survey that in the first half of the year, the company's new product, oral repair membrane, has obtained certification, and calcium silicon bioceramic bone repair material has entered the registration and supplementary application stage. In the future, these two products will enrich the company's layout in the oral sector and strengthen the product portfolio capability. Other pipeline products, such as the uterine repair membrane product, have started the registration-related work, and the data management work for breast patch products is proceeding in an orderly manner, with the expectation that they will also bring incremental revenue to the company in the next 2-3 years. Some of the company's products have potential for overseas expansion, and currently the company is working on the related planning for product overseas expansion.